Peak XV Partners led a $21m Series A funding round in Arintra.

Peak XV Partners, a venture capital and growth investing firm investing across India and Southeast Asia, led a $21m Series A funding round in Arintra, company which provides the industry’s GenAI-native autonomous coding platform, with participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital and Ten13. “At Arintra, we bring together autonomous medical coding, clinical documentation improvement, and denial prevention in a single platform. By helping providers document what was done, code what was documented, and properly support what was charged, we enable them to secure full, compliant reimbursement at a lower cost, with fewer delays and significantly less manual effort,” Preeti Bhargava, Arintra Co-founder and CTO.